MedPage Today) -- SAN FRANCISCO -- A once-yearly intramuscular lenacapavir (Sunlenca) injection was safe and well-tolerated and had higher median levels of plasma concentrations compared with twice-yearly subcutaneous lenacapavir for HIV pre...
Dsn.sebani Ds.tanjangrono RT 04 RW 01 Mojokerto-Jawa Timur
+6281993868686
lita@gdrive.or.id
Copyright © 2023 saktinews. All Rights Reserved